Markets:

Overview

News

Currencies

International

Treasuries

IO Biotech, Inc. - Common Stock (NQ:IOBT)

0.7272 -0.0619 (-7.84%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 25, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about IO Biotech, Inc. - Common Stock

< Previous 1 2 3 4 Next >

Top movers in Tuesday's session ↗

August 12, 2025

Intrigued by the market activity in the middle of the day on Tuesday? Uncover the key winners and losers of today's session in our insightful analysis.

Via Chartmill

These stocks are moving in today's after hours session ↗

August 11, 2025

As the regular session of the US market on Monday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.

Via Chartmill

Which stocks are experiencing notable movement on Monday? ↗

August 11, 2025

Wondering how the US markets performed one hour before the close of the markets on Monday? Discover the movers and shakers of today's session in our comprehensive analysis.

Via Chartmill

12 Health Care Stocks Moving In Monday's Intraday Session ↗

August 11, 2025

Via Benzinga

Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗

August 11, 2025

Here are the top movers in Monday's session, showcasing the stocks with significant price changes.

Via Chartmill

IO Biotech Stock Slumps After Trial Of Cancer Therapy Plus Keytruda Misses Study Goal: Retail Sees Shares Rise 10x ↗

August 11, 2025

The company said Cylembio plus Keytruda demonstrated clinical improvement in progression-free survival compared to Keytruda alone, but statistical significance was “narrowly” missed.

Via Stocktwits

IO Biotech's Combo Therapy For Skin Cancer Falls Just Short, Eyes FDA Talks Later This Year ↗

August 11, 2025

IO Biotech's Phase 3 trial showed Cylembio plus Keytruda improved progression-free survival in advanced melanoma across most subgroups.

Via Benzinga

Monday's pre-market session: top gainers and losers ↗

August 11, 2025

Before the opening bell on Monday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.

Via Chartmill

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

August 11, 2025

Via Benzinga

What's going on in today's after hours session ↗

July 11, 2025

Discover the top movers in Friday's after-hours session and stay informed about the post-market dynamics.

Via Chartmill

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

May 27, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

May 23, 2025

Via Benzinga

Which stocks are experiencing notable movement on Tuesday? ↗

March 25, 2025

Keep an eye on the top gainers and losers in Tuesday's session, as they reflect the most notable price movements.

Via Chartmill

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

March 25, 2025

Via Benzinga

Why Five Below Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket ↗

March 20, 2025

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

January 27, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

November 29, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

November 22, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

October 04, 2024

Via Benzinga

Why Intuitive Machines Shares Are Trading Higher By Around 41%; Here Are 20 Stocks Moving Premarket ↗

September 18, 2024

Via Benzinga

Why Exicure Shares Are Trading Higher By Over 49%; Here Are 20 Stocks Moving Premarket ↗

September 16, 2024

Via Benzinga

Crude Oil Dips Over 4%; SPAR Group Shares Spike Higher ↗

September 03, 2024

Via Benzinga

Why Recursion Pharmaceuticals Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

September 03, 2024

Via Benzinga

Nasdaq Dips Over 2%; US Construction Spending Falls In July ↗

September 03, 2024

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

September 02, 2024

Via Benzinga

IOBT Stock Earnings: IO Biotech Beats EPS for Q2 2024 ↗

August 13, 2024

IOBT stock results show that IO Biotech beat analyst estimates for earnings per share the second quarter of 2024.

Via InvestorPlace

3 Undervalued Biotech Gems With 200%+ Analyst Price Targets ↗

July 04, 2024

These three undervalued biotech stocks have begun garnering investor attention as their treatments show promise.

Via InvestorPlace

IOBT Stock Earnings: IO Biotech Beats EPS for Q1 2024 ↗

May 14, 2024

IOBT stock results show that IO Biotech beat analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

March 06, 2024

Via Benzinga

IOBT Stock Earnings: IO Biotech Misses EPS for Q4 2023 ↗

March 05, 2024

IOBT stock results show that IO Biotech missed analyst estimates for earnings per share the fourth quarter of 2023.

Via InvestorPlace

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

IO Biotech, Inc. - Common Stock (NQ:IOBT)

All News about IO Biotech, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today